Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report

Three days after beginning treatment with canagliflozin, 76-year-old woman noticed onset of bilateral thigh pain & weakness. Lab report showed rhabdomyolysis, hepatocellular injury & rosuvastatin level of 176 ng/mL (>15-fold higher than mean value expected in patients on 40mg/d).


Annals of Internal Medicine